Literature DB >> 24573653

Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.

J Vorwergk1, M P Radosa, K Nicolaus, N Baus, J Jimenez Cruz, M Rengsberger, M Gajda, H Diebolder, I B Runnebaum.   

Abstract

PURPOSE: Hysterectomy for benign conditions can be combined with bilateral salpingectomy to prevent re-intervention for malignant or benign fallopian tube pathologies. The objective of this study was to evaluate the benefit of prophylactic bilateral salpingectomy (PBS) in standard hysterectomy in premenopausal women.
METHODS: This retrospective cohort study included all premenopausal patients at our institution who underwent laparoscopically assisted vaginal hysterectomy (LAVH) without oophorectomy for benign pathologies between 2001 and 2007 [PBS group (LAVH + PBS), 2006-2007; non-PBS group (LAVH without PBS), 2001-2005]. Electronic and paper-based files as well as questionnaire responses were analyzed. In 2010, a survey on patients of a non-BRCA background with and without PBS was requested to complete a standardized questionnaire. Data were analyzed for differences between both subgroups regarding surgical outcome and adnexal pathologies as reported in the postoperative follow-up.
RESULTS: Surgical outcomes of 540 patients (PBS: 127; non-PBS: 413) revealed no difference between groups. No preneoplastic or malignant lesions were diagnosed in the fallopian tubes. Follow-up (non-PBS 92 months, PBS 55 months; p < 0.01) responses from 295 (54.6 %) patients showed a higher incidence of benign adnexal pathologies in the non-PBS group (26.9 vs. 13.9 %; p = 0.02). The rate of LAVH-related surgical re-intervention was higher in the non-PBS group (12.56 vs. 4.16 %; p = 0.04). No malignant neoplasm was reported in the cohort.
CONCLUSIONS: PBS did not increase the complication rate and reduced the incidence of adnexal pathologies requiring surgical re-intervention. Prospective trials should clarify the impact of PBS on cancer mortality.

Entities:  

Mesh:

Year:  2014        PMID: 24573653     DOI: 10.1007/s00432-014-1622-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Laparoscopically-assisted vaginal hysterectomy (LAVH)--an alternative to abdominal hysterectomy.

Authors:  K Devendra; S K Tay
Journal:  Singapore Med J       Date:  2002-03       Impact factor: 1.858

2.  Five minutes of extended assisted ventilation with an open umbilical trocar valve significantly reduces postoperative abdominal and shoulder pain in patients undergoing laparoscopic hysterectomy.

Authors:  Julia C Radosa; Marc P Radosa; Russalina Mavrova; Achim Rody; Ingo Juhasz-Böss; David Bardens; Karin Brün; Erich-Franz Solomayer; Sascha Baum
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-08-12       Impact factor: 2.435

3.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

Review 4.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

5.  Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx.

Authors:  Ilan E Timor-Tritsch; Ana Monteagudo; Tanya Tsymbal
Journal:  J Clin Ultrasound       Date:  2010-09       Impact factor: 0.910

6.  The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study.

Authors:  Abraham N Morse; Clayton B Schroeder; Javier F Magrina; Maurice J Webb; Peter C Wollan; Barbara P Yawn
Journal:  Am J Obstet Gynecol       Date:  2006-03-30       Impact factor: 8.661

Review 7.  The post-reproductive Fallopian tube: better removed?

Authors:  J Dietl; J Wischhusen; S F M Häusler
Journal:  Hum Reprod       Date:  2011-08-16       Impact factor: 6.918

8.  Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

Authors:  Michael J Callahan; Christopher P Crum; Fabiola Medeiros; David W Kindelberger; Julia A Elvin; Judy E Garber; Colleen M Feltmate; Ross S Berkowitz; Michael G Muto
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

9.  Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.

Authors:  Elke A Jarboe; Alexander Miron; Joseph W Carlson; Michelle S Hirsch; David Kindelberger; George L Mutter; Christopher P Crum; Marisa R Nucci
Journal:  Int J Gynecol Pathol       Date:  2009-07       Impact factor: 2.762

10.  Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010.

Authors:  Rikke Guldberg; Sonja Wehberg; Charlotte Wessel Skovlund; Ole Mogensen; Ojvind Lidegaard
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

View more
  14 in total

Review 1.  Hysterectomy for heavy menstrual bleeding.

Authors:  Eva van der Meij; Mark Hans Emanuel
Journal:  Womens Health (Lond)       Date:  2016-01-12

2.  Uterosacral vault suspension (USLS) at the time of hysterectomy: laparoscopic versus vaginal approach.

Authors:  Sara Houlihan; Shunaha Kim-Fine; Colin Birch; Selphee Tang; Erin A Brennand
Journal:  Int Urogynecol J       Date:  2018-11-05       Impact factor: 2.894

3.  Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Authors:  Akila Subramaniam; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Obstet Gynecol       Date:  2018-07       Impact factor: 7.661

4.  Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.

Authors:  Gery Lamblin; Capucine Meysonnier; Stéphanie Moret; Béatrice Nadaud; Georges Mellier; Gautier Chene
Journal:  Int Urogynecol J       Date:  2017-07-13       Impact factor: 2.894

5.  Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar.

Authors:  M Pölcher; S Hauptmann; C Fotopoulou; B Schmalfeldt; I Meinhold-Heerlein; A Mustea; I Runnebaum; J Sehouli
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

6.  Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.

Authors:  Claire Thompson; Ciara McCormick; Waseem Kamran; Ciaran O'Riain; Lucy Norris; David Gallagher; Noreen Gleeson
Journal:  Ir J Med Sci       Date:  2018-01-03       Impact factor: 1.568

Review 7.  Menopausal hormone therapy and breast cancer mortality: clinical implications.

Authors:  Rowan T Chlebowski; Garnet L Anderson
Journal:  Ther Adv Drug Saf       Date:  2015-04

8.  Thirteen Years of Experience with Opportunistic Bilateral Salpingectomy During TLH in Low-Risk Premenopausal Women.

Authors:  P G Paul; Sumina Mannur; Hemant Shintre; George Paul; Gunjan Gulati; Santwan Mehta
Journal:  J Obstet Gynaecol India       Date:  2018-05-16

9.  Feasibility of Risk Reducing Salpingo-Oophorectomy at the Time of Abdominal Surgery for Correction of Pelvic Organ Prolapse and Urinary Incontinence.

Authors:  Ali Azadi; James A Bradley; Greg J Marchand; Douglas J Lorenz; David Doering; Donald R Ostergard
Journal:  Gynecol Minim Invasive Ther       Date:  2021-01-30

10.  Ovarian cancer risk reduction through opportunistic salpingectomy.

Authors:  Janice S Kwon
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.